Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage.

By S. Mayer, N. Brun, K. Begtrup, Joseph Broderick, S. Davis, M. Diringer, B. Skolnick, T. Steiner. New England Journal of Medicine, 2008

1,154 citations recorded by the source corpus.

Subfields: Hematology, Neurology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/58252f106302a907d18a8411f12767e11776eb51

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Neurology

1. Alejandro Rabinstein

Citations in the corpus

• Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage (2016, background): “In a study of noncoagulopathic intraparenchymal hemorrhage patients who received rFVIIa, there was a 5 % excess risk of arterial thrombosis compared to controls [113].”